Views & Analysis Medical technology and digital: primary levers for change What steps can traditional pharma and medtech companies take to update their processes to support a move to more agile, digital business models?
Debates & Insight Sponsored Pricing and Market Access Outlook 2018 This year’s edition of Pricing and Market Access Outlook, our first as IQVIA, identifies a trend towards models that reward value and outcomes.
News A NICE yes for latest immunotherapy Bavencio NICE has recommended Merck KGaA and Pfizer’s Bavencio in previously treated metastatic Merkel Cell Carcinoma, a rare and aggressive form of skin cancer.
News NHS drug deal could fund vital cystic fibrosis research - Ve... Vertex wants long-term funding for CF research
News Call for new restrictions on UK vaccine prices Proposals also include fresh attack on drug prices
News Eisai disappointed after NICE rejects earlier use for breast... NICE says no to Halaven in second line breast cancer
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.